These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3930450

  • 1. Mechanism of synergistic cell killing by hydroxyurea and cytosine arabinoside.
    Tanaka M, Kimura K, Yoshida S.
    Jpn J Cancer Res; 1985 Aug; 76(8):729-35. PubMed ID: 3930450
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E, Eiferman F.
    J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P, Lien EJ, Avramis VI.
    Anticancer Res; 1999 Sep; 19(3A):1625-33. PubMed ID: 10470093
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J, Kerrigan D, Nichols M, Shackney S, Zwelling LA.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
    Grem JL, Allegra CJ.
    Cancer Res; 1990 Nov 15; 50(22):7279-84. PubMed ID: 1699659
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F, Cadman E.
    Cancer Res; 1983 Jun 15; 43(6):2688-93. PubMed ID: 6189585
    [Abstract] [Full Text] [Related]

  • 7. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I, Saito S, Hori K, Suzuki M, Sato H.
    Cancer Res; 1982 Jul 15; 42(7):2846-51. PubMed ID: 7083175
    [Abstract] [Full Text] [Related]

  • 8. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS, Occhipinti SJ, Cunningham RE, Shackney SE.
    Cancer Res; 1981 Oct 15; 41(10):3881-4. PubMed ID: 7284997
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S, Bhalla K, Rauscher F, Cadman E.
    Cancer Res; 1983 Nov 15; 43(11):5093-100. PubMed ID: 6577943
    [Abstract] [Full Text] [Related]

  • 10. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
    Liliemark JO, Plunkett W.
    Cancer Res; 1986 Mar 15; 46(3):1079-83. PubMed ID: 3484676
    [Abstract] [Full Text] [Related]

  • 11. Differential effect of interleukin 3 on the metabolism of high-dose cytosine arabinoside in normal versus leukemic human bone marrow cells.
    Bhalla K, Birkhofer M, Arlin Z, Grant S, Lutzky J, Safah H, Graham G.
    Exp Hematol; 1991 Aug 15; 19(7):669-73. PubMed ID: 1893953
    [Abstract] [Full Text] [Related]

  • 12. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov 15; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of cytotoxicity of 1-beta-D-arabinofuranosylcytosine for K562 human leukemic cells by cadeguomycin.
    Suzuki H, Kim SH, Tanara M, Okazaki K, Okabe T, Wu RT, Tanaka N.
    Cancer Res; 1987 Feb 01; 47(3):713-7. PubMed ID: 3467840
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
    Kubota M, Takimoto T, Tanizawa A, Akiyama Y, Mikawa H.
    Biochem Pharmacol; 1988 May 01; 37(9):1745-9. PubMed ID: 2454114
    [Abstract] [Full Text] [Related]

  • 16. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity.
    Tanaka M, Yoshida S.
    Jpn J Cancer Res; 1987 Aug 01; 78(8):851-7. PubMed ID: 3115933
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
    Swinnen LJ, Ellis NK, Erickson LC.
    Cancer Res; 1991 Apr 15; 51(8):1984-9. PubMed ID: 2009517
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
    Vilpo JA, Vilpo LM.
    Cancer Res; 1988 Jun 01; 48(11):3117-22. PubMed ID: 3163271
    [Abstract] [Full Text] [Related]

  • 20. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
    Ross DD, Akman SA, Joneckis CC, Yang E, Bachur NR.
    Cancer Res; 1984 Apr 01; 44(4):1530-5. PubMed ID: 6584206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.